Nitric Oxide Synthetic Pathway in Patients with Microvascular Angina and Its Relations with Oxidative Stress

Table 1

Demographic and clinical characteristics of the subjects.

Variable	MVA (𝑛=25)	CAD (𝑛=22)	Ctrl (𝑛=20)
Age (years)	56.5±10.3	66.1±8.6	55.5±10.2
Male gender	14 (56.0)	17 (77.3)	14 (70)
BMI	25.8±3.3	27.3±3.11	24.36±2.35
Total cholesterol (mg/dL)	226.9±59.2	208.3±29.2	208.1±26.8
HDL-cholesterol (mg/dL)	54.9±17.3	46.9±17.2	54.5±17.3
LDL-cholesterol (mg/dL)	150.0±52.4	133.8±36.8	132.3±22.1
Triglycerides (mg/dL)	105.5±66.9	131.5±69.4	95.5±32.5
Systolic blood pressure (mmHg)	130.0±13.2	138.9±18.3	130.0±14.0
Diastolic blood pressure (mmHg)	78.0±8.3	80.0±9.1	78.0±6.0
Creatinine (mg/dL)	0.85±0.22	0.86±0.22	0.81±0.14
Current smoker	3 (12.0)	3 (13.64)	0 (0)
Hypercholesterolemia	14 (56.0)	14 (63.6)	2 (12.5)
Hypertriglyceridemia	1 (4.0)	2 (9.1)	1 (6.25)
Hypertension	11 (44.0)	14 (63.6)	2 (12.5)
Pharmacological treatments
Converting enzyme inhibitors	2 (8.0)	6 (27.3)	0 (0)
Antithrombotics	23 (85.1)	17 (77.3)	0 (0)
Beta-blockers	10 (40.0)	5 (23.8)	1 (5.88)
Calcium channel blockers	1 (4.0)	4 (18.2)	1 (5.88)
Diuretics	2 (8.0)	2 (9.1)	0 (0)
Statins	4 (16.0)	4 (18.2)	2 (11.8)
Hypoglycemics	0 (0)	0 (0)	0 (0)
Angiotensin receptor blockers	4 (16.0)	6 (27.3)	0 (0)

Quantitative variables are expressed as mean ± SD and categorical variables as 𝑛 (%).